الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 83 |  |  |
| | | from | 83 | | |
Abstract
Background: CO measurement is essential for guiding therapeutic decisions in critically ill patients. Electrical cardiometry, which is based on thoracic electrical bioimpedance, can measure CO in a continuous and non-invasive way. The benefits of EC are continuous monitoring, low time consumption, portability, and user independence. Trans-thoracic echocardiography has been commonly used as a non-invasive method to assess CO despite being noncontiguous and operator-dependent.
Aim of the work: The objective of this study is to compare EC and Echo in measuring CO in septic shock patients, as well as to assess the reliability and accuracy of EC for non-invasive CO monitoring.
Patients and methods: A prospective cohort study was conducted on 50 adult patients admitted to the Critical Care Medicine Department in Alexandria Main University Hospital, diagnosed with septic shock according to the surviving sepsis campaign, and fulfilling the inclusion and exclusion criteria from January 2023 to October 2023. Standard 12 leads ECG assessment was done on all patients to detect rhythm and exclude ischemic changes. At the time of ICU admission, all the patients underwent history taking and physical examination, laboratory assessment, and echocardiographic assessment. Physical examination including vital signs, mean arterial blood pressure, APACHE-II score, and SOFA score was done. Laboratory assessment including CBC, kidney function test, arterial blood gases, and coagulation profile was done. Patients were treated according to the surviving sepsis campaign guidelines. EC was applied to all included patients to determine SV, CO, and other hemodynamic parameters within 24 hours of admission, and trans-thoracic echocardiographic assessment was done on all patients including LVEDV, LVESV, SV, EF, LVOT, and VTI within 24 hours of admission.